The ultimate goal when adopting AI tools should be to reduce friction while keeping clinical and operational judgment at the ...
WAVE Life Sciences (NASDAQ:WVE) outlined progress across its obesity-focused siRNA program and RNA editing pipeline during a Chardan discussion, with President and CEO Paul Bolno emphasizing the ...
Life sciences organizations have invested heavily in data and analytics, yet timely decision making remains a challenge. | Within3 leaders discuss why ownership, insight sharing and human judgment are ...
Boost ROI with robust data foundations and AI-led trial acceleration, patient finding, safety detection, market access and field-force effectivenessDublin, Oct. (GLOBE NEWSWIRE) -- "Life Science ...
Oracle announced the Oracle Life Sciences AI Data Platform, a generative AI-enabled solution designed to empower pharmaceutical, medical device, research, and life sciences organizations to accelerate ...
The multisector REDI Initiative brings together leaders and experts across academia, industry, government, philanthropy, and nonprofit organizations to advance a future-oriented and resilient biodata ...
Biologists have launched a database of marine animals’ body sizes that they say could help preserve biodiversity in Earth’s oceans. Why bother measuring animals’ body size? In an article in Global ...
Phase 1b study in atopic dermatitis demonstrated a statistically significant mean reduction of 2.1 years in measured skin epigenetic age after four weeks of treatment with RLS-1496 (p=0.032), with ...
In the coming year, the life sciences industry is expected to evolve, shape, and transform under pressures from both internal and external forces. Industry leaders anticipate that, despite potential ...
For Healthcare and Life Sciences (HLS) organizations, data plays a critical role in providing the most effective care and developing innovative treatments. Even more important, however, is ensuring ...
The U.S. life sciences industry entered 2026 with surprising momentum, following threats of tariffs and disrupted trade, NIH funding cuts, and a sluggish IPO market. Accounting for more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results